Your browser doesn't support javascript.
loading
TRB CDR3-cancer testis antigen chemical complementarity scoring for identifying productive immune responses in renal cell carcinoma.
Hudock, Tabitha R; Barker, Vayda R; Manley, Brandon J; Chobrutskiy, Andrea; Chobrutskiy, Boris I; Diaz, Michael J; Song, Joanna J; Blanck, George.
Afiliação
  • Hudock TR; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
  • Barker VR; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
  • Manley BJ; Department of Genitourinary Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Chobrutskiy A; Department of Pediatrics, Oregon Health and Science University Hospital, Portland, OR, USA.
  • Chobrutskiy BI; Department of Internal Medicine, Oregon Health and Science University Hospital, Portland, OR, USA.
  • Diaz MJ; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
  • Song JJ; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
  • Blanck G; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Cancer Biomark ; 38(1): 103-110, 2023.
Article em En | MEDLINE | ID: mdl-37545223
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Cancer Biomark Assunto da revista: BIOQUIMICA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Cancer Biomark Assunto da revista: BIOQUIMICA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos